SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Research

Read more breaking news

 

 

New results show guggulipid extract fails to lower cholesterol

13-Aug-2003

A guggulipid extract, used as an alternative to cholesterol-lowering drugs in Asia, has turned out to be no more effective than a placebo in clinical trials, report researchers in yesterday's Journal of the American Medical Association (JAMA).

"We found that the guggulipid product did not lower the level of LDL-C (low density lipoprotein cholesterol) in our trial participants, but actually raised LDL-C slightly," said Dr Philippe O. Szapary, assistant professor of Medicine at the University of Pennsylvania School of Medicine and principal author of the study.

Recently, guggulsterones, the bioactive compounds of guggul, have been shown to be potent antagonists of two nuclear hormone receptors involved in cholesterol metabolism, establishing a plausible mechanism of action for the hypolipidemic effects of these extracts. However, there is little data on the use of guggul extracts in Western populations.

The randomised, double-blind, eight-week study included 103 healthy adults with raised cholesterol levels who were divided into three groups. One group was given a standard dose (1000mg) of a standardized guggul extract (guggulipid, containing 2.5 per cent guggulsterones) three times daily; a second group was given a high dose of 2,000 mg of the extract; and the third group was given the placebo. All continued eating typical Western diets.

"We found LDL-C increased by 4 per cent in the standard-dose group and 5 per cent in the high-dose group. At the same time, it decreased by 5 per cent in the placebo group," Szapary said. Low-density lipoprotein can lead to heart disease by accumulating on arterial walls.

The researchers also reported that a small subset of patients taking the herb developed a rash "indicating they were experiencing hypersensitivity drug reactions". The rash disappeared when they stopped taking the supplement.

"Our findings do not support the use of guggulipid to control LDL-C in the general population," Szapary concluded. He added that the results "strengthen our belief that dietary supplements need to be studied in a rigorous way, to test both their safety and their efficacy".

Szapary is extending the study to investigate further the effects of guggulipid on triglycerides, or blood fats, and inflammation, both of which appeared to be more responsive than cholesterol to the effects of the herb in the clinical study.

Guggulipid, a substance derived from one of the fabled myrrh plants of the Middle East, has a 2,600-year tradition in traditional medicine. Indian practitioners of ayuvedic medicine have used the herb in holistic regimens combining meditation, yoga and diet to treat obesity, atherosclerosis, high cholesterol and arthritis.

The study was partly funded by Sabinsa, a US manufacturer of a guggulipid extract product.

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars